Intrinsiqs

Is Telomir Pharmaceuticals, Inc. Common Stock overvalued?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) — key valuation metrics and fundamentals.

No verdict
Price
$1.08
Fair value
Current P/E
Normal P/E
Market cap
$74.2M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares TELO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 13 Aug 2026.